SHARP hypofractionated stereotactic radiotherapy is well tolerated in prostate cancer: Toxicity and quality of life assessment

Por Rucinska, Monika, Kieszkowska-Grudny, Anna, Nawrocki, Sergiusz
Publicado no Strahlenther Onkol (2016)

The Waiting Time of Prostate Cancer Patients in Poland

Por Osowiecka, Karolina, Nawrocki, Sergiusz, Kurowicki, Marcin, Rucinska, Monika
Publicado no Int J Environ Res Public Health (2019)

How Long Are Cancer Patients Waiting for Oncological Therapy in Poland?

Por Osowiecka, Karolina, Rucinska, Monika, Nowakowski, Jacek J., Nawrocki, Sergiusz
Publicado no Int J Environ Res Public Health (2018)

Sequencing postoperative radiotherapy and adjuvant chemotherapy in non-small cell lung cancer: unanswered questions on the not evidence-based approach

Por Kepka, Lucyna, Socha, Joanna, Rucinska, Monika, Wasilewska-Tesluk, Ewa, Komosinska, Katarzyna
Publicado no J Thorac Dis (2016)

Smoking during radiotherapy for head and neck cancer and acute mucosal reaction

Por Szeszko, Beata, Osowiecka, Karolina, Rucińska, Monika, Wasilewska-Teśluk, Ewa, Gliński, Krzysztof, Kępka, Lucyna
Publicado no Rep Pract Oncol Radiother (2015)

CA-SSR1 Polymorphism in Intron 1 of the EGFR Gene in Patients with Malignant Tumors Who Develop Acneiform Rash Associated with the Use of Cetuximab

Por Jarząbek, Tomasz, Rucińska, Monika, Rogowski, Wojciech, Lewandowska, Marzena, Tujakowski, Jerzy, Habib, Maja, Kowalczyk, Anna, Byszek, Agnieszka, Dziadziuszko, Rafał, Nawrocki, Sergiusz
Publicado no Mol Diagn Ther (2015)